Allison McGeer

University of Toronto

SCHOLARLY PAPERS

5

DOWNLOADS

190

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (5)

1.

Global Serotype Distribution of Remaining Invasive Pneumococcal Disease after Extensive Use of Pcv10/13: The Pserenade Project

Number of pages: 59 Posted: 13 Mar 2024
Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University - International Vaccine Access Center, Johns Hopkins University - Department of Epidemiology, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, RWTH Aachen University - RWTH University Hospital Aachen, University of Amsterdam - Department of Medical Microbiology and Infection Prevention, Consejería de Sanidad - Servicio de Epidemiología, Yale University - Institute for Global Health, affiliation not provided to SSRN, Centers for Disease Control & Prevention - National Center for Immunization and Respiratory Diseases, Centre Hospitalier Intercommunal de Créteil, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, University of West Attica, National Institute of Public Health, affiliation not provided to SSRN, World Health Organization, Government of the United Kingdom - NHS Greater Glasgow and Clyde, London School of Hygiene & Tropical Medicine, Epiconcept, Riga Stradins University, University of Melbourne - Murdoch Children's Research Institute, World Health Organization (WHO), Toyama Institute of Health - Department of Bacteriology, Tampere University - Faculty of Social Sciences, INEI - ANLIS “Dr. Carlos G. Malbrán" - Servicio de Bacteriología Clínica, World Health Organization’s Regional Office for Africa, Hospital Sant Joan de Deu - Molecular Microbiology Department, Public Health Agency of Sweden, Australian Government - Centre for Disease Control, University of Toronto, Regional Authority of Public Health - National Reference Centre for Pneumococcal and Haemophilus Diseases, London School of Hygiene & Tropical Medicine - Medical Research Council Unit: The Gambia, LACEN - Laboratório Central de Saúde Pública, Public Health England - Immunisation and Countermeasures Division, Landspitali - The National University Hospital - Department of Clinical Microbiology, National Institute of Public Health, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, Kaiser Permanente Northern California - Kaiser Permanente Vaccine Study Center, University of Calgary, University of Sydney, The University of Hong Kong - Department of Microbiology, University of Bern, Centers for Disease Control and Prevention - Arctic Investigations Program, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, National Institute of Public Health, ESR (Institute of Environmental Science and Research) - Health Intelligence Team, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, University of Liverpool, Mohammed VI University of Health Sciences, KU Leuven - University Hospitals Leuven, Université Laval, Statens Serum Institut, Ben-Gurion University of the Negev - Faculty of Health Science, Children’s Health Ireland at Temple Street - Irish Meningitis and Sepsis Reference Laboratory, European Centre for Disease Prevention and Control, Instituto Costarricense de Investigación y Enseñanza en Nutrición y Salud, Instituto de Salud Pública y Laboral de Navarra, Italian National Institute of Health, National Centre for Infectious Diseases, University of Utah Health Sciences Center - Division of Pediatric Infectious Diseases, Instituto Adolfo Lutz, Instituto de Salud Pública de Chile, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center and Independent
Downloads 93 (513,683)

Abstract:

Loading...

IPD, PCV impact, global, serotype distribution, all ages

2.

Global Impact of 10- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project

Number of pages: 36 Posted: 19 Mar 2024
Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, University of Oxford - KEMRI-Coast Centre for Geographical Medicine and Research, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University - Department of Epidemiology, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, University of Massachusetts Worcester - UMass Chan Medical School, Johns Hopkins University - Johns Hopkins Bloomberg School of Public Health, World Health Organization (WHO) - Department of Immunizations, Vaccines and Biologicals, Yale University - Institute for Global Health, OsloMet - Oslo Metropolitan University - Faculty of Health Sciences, University of the Witwatersrand - Department of Clinical Microbiology and Infectious Diseases, Santé Publique France, RWTH Aachen University - RWTH University Hospital Aachen, Statens Serum Institut - Infectious Disease Epidemiology & Prevention, Mie National Hospital, National Institute for Public Health and Environment, National Medicines Institute, National Institute of Public Health, London School of Hygiene & Tropical Medicine, Epiconcept, Riga Stradins University, Rey Juan Carlos University, University of Melbourne - Murdoch Children's Research Institute, University of Calgary, Institute of Public Health of Chile - National Agency for Medical Devices, Innovation and Development (ANDID), Tampere University - Faculty of Social Sciences, Health Protection Surveillance Centre (HPSC), Australian Government - Centre for Disease Control, University of Toronto, Regional Authority of Public Health - National Reference Centre for Pneumococcal and Haemophilus Diseases, London School of Hygiene & Tropical Medicine - Medical Research Council Unit: The Gambia, Government of the United Kingdom - Public Health Scotland, Public Health Agency of Sweden, Public Health England - Immunisation and Countermeasures Division, Landspitali - The National University Hospital - Department of Clinical Microbiology, National Institute of Public Health, Kaiser Permanente Northern California - Kaiser Permanente Vaccine Study Center, University of Sydney, The University of Hong Kong - Department of Microbiology, University of Bern, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Child Health Research Foundation, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), National Institute of Public Health, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, National Public Health Organization, Athens, affiliation not provided to SSRN, Mohammed VI University of Health Sciences, KU Leuven - University Hospitals Leuven, Université Laval, Ben-Gurion University of the Negev - Faculty of Health Science, European Centre for Disease Prevention and Control, National Health Laboratory Services (NHLS) - Centre for Respiratory Diseases and Meningitis, Generalitat de Catalunya, Ministry of Health, Kenya Medical Research Institute (KEMRI), Italian National Institute of Health, Government of the United States of America - National Center for Emerging and Zoonotic Infectious Diseases, Instituto Adolfo Lutz, Kenya Medical Research Institute (KEMRI), University of Utah Health Sciences Center - Division of Pediatric Infectious Diseases, Johns Hopkins Bloomberg School of Public Health - Department of International Health, International Vaccine Access Center, Johns Hopkins University - International Vaccine Access Center and Independent
Downloads 57 (673,491)
Citation 1

Abstract:

Loading...

invasive pneumococcal disease, pneumococcal conjugate vaccines, serotypes, vaccine impact, incidence, serotype replacement, indirect protection

3.

Prospective Decentralized Study Evaluating Antibody Responses to COVID-19 Vaccines in Community Dwelling Adults to 48 Weeks Post Primary Vaccine Series

Number of pages: 47 Posted: 09 Jan 2023
University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - University Health Network, Sinai Health System TorontoUniversity of Toronto - Centre for Global Health Research, University of Toronto, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto, University of Toronto, University of Toronto - University Health Network, University of Toronto, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - University Health Network, University of Toronto - Lunenfeld-Tanenbaum Research Institute and University of Toronto - Mount Sinai Hospital, Toronto
Downloads 15 (1,007,068)

Abstract:

Loading...

4.

Immunogenicity of Convalescent and Vaccinated Sera Against Clinical Isolates of Ancestral SARS-CoV-2, Beta, Delta, and Omicron Variants

Number of pages: 21 Posted: 10 Feb 2022
University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Saskatchewan - Vaccine and Infectious Disease Organization, Laboratory of Shenzhen Children’s Hospital, Sunnybrook Research Institute, Dalhousie University, Sunnybrook Research Institute, University of Saskatchewan, Students, University of Saskatchewan, Students, University of Saskatchewan - Vaccine and Infectious Disease Organization, University of Toronto, Toronto, Canada - Department of Medicine, Mount Sinai Health System, Mount Sinai Health System, Mount Sinai Health System, University of Toronto - University Health Network, University of Toronto - Mount Sinai Hospital, Toronto, Mount Sinai Health System, University of Toronto - Department of Laboratory Medicine and Pathobiology, Sinai Health System TorontoUniversity of Toronto - Centre for Global Health Research, University of Toronto, Sunnybrook Research Institute and University of Saskatchewan - Vaccine and Infectious Disease Organization
Downloads 13 (1,027,679)

Abstract:

Loading...

SARS-CoV-2, neutralization, variants of concern, omicron, vaccine, neutralizing antibodies

5.

Clinical Performance of Three Commercial and Two In-House Multiplex Assays for SARS-CoV-2 Antibody Detection in Dried Blood Spot Specimens

Number of pages: 121 Posted: 14 Mar 2022
Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, University of Ottawa, University of Ottawa, University of Ottawa - Department of Biochemistry, Microbiology and Immunology, Sinai Health System TorontoUniversity of Toronto - Centre for Global Health Research, University of Toronto - Mount Sinai Hospital, Toronto, University of Toronto, Public Health Agency of Canada, Public Health Agency of Canada, Public Health Agency of Canada, National Research Council Canada, McGill University, McGill University - Meakins-Christie Laboratories, Public Health Agency of Canada and Public Health Agency of Canada
Downloads 12 (1,037,594)

Abstract:

Loading...